StockData
Bluejay Diagnostics, Inc. logo

Bluejay Diagnostics, Inc. (BJDX) stock

BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$2.15−0.14 (-5.90%)

Close on Nov 17, 2026Market cap $9.63MP/E –Yield –

Bluejay Diagnostics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Bluejay Diagnostics's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.90M. For fiscal 2025 it was -$6.05M. The highest annual figure on record is -$508.71K in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.05M–
FY2024Dec 31, 2024-$7.82M–
FY2023Dec 31, 2023-$8.31M–
FY2022Dec 31, 2022-$7.74M–
FY2021Dec 31, 2021-$4.37M–
FY2020Dec 31, 2020-$508.71K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.50M–
Q1 FY2026Mar 31, 2026-$1.59M–
Q4 FY2025Dec 31, 2025-$1.45M–
Q3 FY2025Sep 30, 2025-$1.36M–
Q2 FY2025Jun 30, 2025-$2.05M–
Q1 FY2025Mar 31, 2025-$1.18M–
Q4 FY2024Dec 31, 2024-$1.45M–
Q3 FY2024Sep 30, 2024-$2.15M–
Q2 FY2024Jun 30, 2024-$1.91M–
Q1 FY2024Mar 31, 2024-$2.30M–
Q4 FY2023Dec 31, 2023-$2.78M–
Q3 FY2023Sep 30, 2023-$1.13M–
Q2 FY2023Jun 30, 2023-$1.48M–
Q1 FY2023Mar 31, 2023-$2.93M–
Q4 FY2022Dec 31, 2022-$2.94M–
Q3 FY2022Sep 30, 2022-$1.26M–
Q2 FY2022Jun 30, 2022-$1.66M–
Q1 FY2022Mar 31, 2022-$1.88M–
Q4 FY2021Dec 31, 2021-$2.52M–
Q3 FY2021Sep 30, 2021-$1.11M–
Q2 FY2021Jun 30, 2021-$356.18K–
Q1 FY2021Mar 31, 2021-$372.62K–
Q4 FY2020Dec 31, 2020-$154.86K–

More Bluejay Diagnostics figures

See a number that looks wrong?